AMANDA MAYERS: Open Payments
NPI 1205524543 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,330 in 25 payments from 9 companies in 2025. Trend: 2023 $59 · 2024 $731 · 2025 $1,330
Food & beverage: $1,330
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 11 | $404 |
| CeQur Corporation | 1 | $306 |
| Insulet Corporation | 1 | $150 |
| Corcept Therapeutics | 1 | $129 |
| Dexcom, Inc. | 4 | $110 |
| Ascensia Diabetes Care Us Inc. | 1 | $97 |
| Novo Nordisk Inc | 4 | $96 |
| Lilly USA, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: GVOKE HYPOPEN, CeQur Simplicity, OMNIPOD, Korlym, Dexcom G6 Transmitter, Rybelsus, Ozempic, MOUNJARO.
Industry payments across FL — which companies pay providers there.
